4.7 Article

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice

Philippe Gallay et al.

PLOS ONE (2019)

Review Cell Biology

Potential role of cyclophilin A in regulating cytokine secretion

Farman Ullah Dawar et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2017)

Article Gastroenterology & Hepatology

The epidemiology of non-alcoholic fatty liver disease

Stefano Bellentani

LIVER INTERNATIONAL (2017)

Article Cell Biology

Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β

Kevin M. Hart et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Article Multidisciplinary Sciences

Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma

Viviana Casagrande et al.

SCIENTIFIC REPORTS (2017)

Article Biochemistry & Molecular Biology

Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection

Magnus Joakim Hansson et al.

CHEMISTRY & BIOLOGY (2015)

Article Pharmacology & Pharmacy

IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression

Daniel A. Giles et al.

CURRENT DRUG TARGETS (2015)

Article Oncology

Emerging Trends in Hepatocellular Carcinoma: Focus on Diagnosis and Therapeutics

Avegail Flores et al.

CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2014)

Review Cell Biology

Cyclophilin A: a key player for human disease

P. Nigro et al.

CELL DEATH & DISEASE (2013)

Article Surgery

Liver Transplantation for Nonalcoholic Steatohepatitis The New Epidemic

Vatche G. Agopian et al.

ANNALS OF SURGERY (2012)

Review Biochemistry & Molecular Biology

Cyclophilin involvement in the replication of hepatitis C virus and other viruses

James Baugh et al.

BIOLOGICAL CHEMISTRY (2012)

Review Gastroenterology & Hepatology

Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review

Donna L. White et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Microbiology

Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin Family

Matthew A. Gregory et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Gastroenterology & Hepatology

Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States

Michael R. Charlton et al.

GASTROENTEROLOGY (2011)

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

Article Cell Biology

Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9

Mingjun Zhang et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)

Review Gastroenterology & Hepatology

Molecular targeted therapies in hepatocellular carcinoma

Josep M. Llovet et al.

HEPATOLOGY (2008)

Article Physiology

Impact of genetic background on nephropathy in diabetic mice

SB Gurley et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)

Article Chemistry, Multidisciplinary

Sanglifehrin-cyclophilin interaction: Degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data

R Sedrani et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)